The present studies were carried out to assess the metabolic differences
INTRODUCTION
It has been known1 that long chain fatty acid absorbed from the intestinal lumen to intestinal epithelial cells is transported to intestinal lymphatics after the several processes in absorptive cells such as resynthesis of triglyceride and lipoprotein formation. In recent years the progress of jejunal fiberscopy make it clear that2,3 in many small intestinal diseases we can see such a characteristic findings as white villi or scattered white spots on jejunum which may correspond to the disturbance of transportation of lipid into lymphatics. The different site of blockade in the process of lipid transportation from intestinal lumen to lym phatics is now to become known4,5,6,7 in these diseases by the use of drugs which cause similar diseased condition in animals. On the other hand, the decreased rate of unsaturated fatty acid such as linoleic acid or arachidoic acid is ob serveds in fatty acid composition of plasma lipid taken from patients with malabsorption in fasting state. This observation raises the possibility that in patients with malabsorption the absorption of unsaturated fatty acid from dis eased bowel is affected more severely than the saturated one. Actually, several reports9,10 have suggested the differences in the intestinal absorption of saturated and unsaturated long chain fatty acid. However, little is known about the exact site of difference in the process of absorption and transportation to lymphatics between unsaturated and saturated long chain fatty acid. We therefore tried to assess the effect of different site of block in absorptive cells on lymphatic absorp tion of saturated and unsaturated fatty acid by the use of puromycin,11 an in hibitor of protein synthesis in absorptive cells and colchicine,7 an inhibitor of microtubular function. Colchicine was dissolved in 0.9% NaCl and injected intraperitoneally in a dose of 5 mg/kg of body weight, 2 hr before the administration of mixed micellar solution to lymph-fistula rats.
ANALYSIS OF LYMPH SAMPLES :
Lymph samples were collected at halfhourly or hourly intervals into ice chilled heparinized tubes. Lymph samples were assayed for radioactivity by adding 0.3 ml of lymph to 12 ml of a scintillation solution Aquasol 2(New Eng land Nuclear, Boston Mass.). Assays for radioactivity were carried out in a Beckman LS-230 liquid scintillation system.
RESULTS
There is a significant difference between saturated (palmitic acid, 16-carbon) and unsaturated (linoleic acid, 18-carbon) long chain fatty acid in the lymphatic absorption after the administration of mixed micelles. In Fig. 2 are shown the values for radioactivity of these two fatty acids found in the intestinal lymph as percentage of that administered.
In animals which was given linoleic acid micelles, more than 87% of the administered [1-14C]linoleic acid was appeared in intestinal lymph over the 6 hr period after the administration of lipid. In contrast, [1-14C] palmitic acid administered with palmitic acid micelles showed a smaller amount of lymphatic appearance of radioactivity with only 68% of 14C radioactivity appearing by 6 hr. In puromycin-treated animals, an inhibition of lymphatic absorption of linoleic acid was observed (Fig. 3) . In control animals, more than 66% of the administered radioactivity of linoleic acid appeared in lymph with the first 90 min after lipid administration.
Puromycin-treated animals, however, demon strated a decreased appearance of radioactivity of linoleic acid in lymph with only 47% of administered lipid appearing by the same hour (0.001<P<0.005, t=4.63).
There was no delayed peak of absorption of linoleic acid in puromycin treated animals. The total recovery of administered [1-14C] linoleic acid over the 6 hr period was reduced in puromycin-treated animals to 61% compared with 87% in control animals (P<0.001, t=5.82).
In case of palmitic acid absorption, however, the prior administration of puromycin was not associated with a sig The effect of colchicine on lymphatic absorption of linoleic acid and palmitic acid was summarized as shown in Fig. 4 . The administration of colchicine was associated with a delay as well as decrease in the lymphatic appearance of intraduodenally administered two kind of labeled fatty acids. Colchicine-treated animals showed an appearance of 19% of administered [1-14C] linoleic acid in lymph by 90 min, whereas control animals showed 66% (P<0.001, t=24.58) . And the total recovery of administered [1-14C]linoleic acid was reduced in colchi cine-treated animals to 51% compared with 87% in control animals (P<0.001, t=6.67).
In case of palmitic acid absorption, the lymphatic appearance of [1-14C] palmitic acid by 90 min was also reduced to 20% compared with 43% in controls (0.01<P<0.02, t=3.60) and the total recovery over the 6 hr period was also reduced to 46% compared with 68% in controls (0.001<P<0.005, t=4.43).
The degree of inhibition between two kind of long chain fatty acid was considered to be not significantly different when colchicine was treated. The absorptive peak of radioactivity was found at the first 30-60 min after the admin istration of linoleic acid as well as palmitic acid micelles to control aniamis.
Colchicine-treated
animals, however, demonstrated a delayed peak of absorption shifting to 60-90 min and significant amount of radioactivity counting to In conclusion, we consider that the difference of lymphatic absorption of linoleic acid and palmitic acid will be mainly caused from the phase of lipoprotein formation during lipid absorption and the phase of lipoprotein secretion will not be attributable.
